At a glance
- Atlas 28, at $406.9 million, is the fourth CLO issued through Crescent's CLO Equity Fund II, which held its final close in August.
- Fund selectors cannot buy into Crescent's CLO Equity Fund II, which closed in August.
- Nilesh Mandhare, managing director and head of CLO issuance at Crescent, said volatility in the leveraged loan market let the team buy assets selectively at attractive prices.
Crescent Capital priced Atlas Senior Loan Fund XXVIII at $406.9 million, its second new-issue CLO of 2026, Alternative Credit Investor reported Nov. 4. The transaction drew 20 investors.
Atlas 28, at $406.9 million, is the fourth CLO issued through Crescent's CLO Equity Fund II, which held its final close in August. The portfolio will hold mainly US senior secured term loans, along with selected senior secured corporate bonds. The size is just above the $404 million Obra Capital reported for its fifth CLO, according to Alternative Credit Investor.
Fund selectors cannot buy into Crescent's CLO Equity Fund II, which closed in August. Further CLOs from the fund will draw on capital already committed.
Nilesh Mandhare, managing director and head of CLO issuance at Crescent, said volatility in the leveraged loan market let the team buy assets selectively at attractive prices. Crescent reports $53 billion in assets under management and just under $20 billion of CLOs issued and managed since 1992.
Reported by the Fund launches & raises desk from Alternative Credit Investor. Published . Corrections